Physician profile
Michael L Waldschmidt
NPI 1811995129
$3,217.05
in general payments reported to CMS, 2019-2025
18 companies · $390 in 2025
The $390 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $320 · 2020: $158 · 2022: $618 · 2023: $712 · 2024: $1,018 · 2025: $390.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,080 · Travel and Lodging: $40.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,080.31 |
| Travel and Lodging | $40.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $865.41 | 2019-2024 | Auryon Laser System 100-120 Vac |
| W. L. Gore & Associates, INC. | $758.40 | 2022-2024 | Gore Viabahn Vbx Balloon Expandable Endo, Gore Viabahn Endoprosthesis |
| Medtronic, INC. | $347.87 | 2022-2023 | Endurant Iis |
| Inari Medical, INC. | $245.33 | 2022 | |
| Cook Medical LLC | $150.73 | 2025 | Zenith |
| Silk Road Medical, INC. | $148.99 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter, Enroute Transcarotid Stent |
| Penumbra, INC. | $142.00 | 2025 | Penumbra System |
| Cardinal Health 200 LLC | $115.44 | 2020 | |
| Lemaitre Vascular, INC. | $105.41 | 2023 | Restoreflow |
| Bard Peripheral Vascular, INC. | $99.95 | 2024 | Crosser Iq, Set Aspirex S 10f 110cm |
| Boston Scientific Corporation | $97.26 | 2025 | Enroute Transcarotid Stent |
| Biocompatibles, INC. | $36.02 | 2019 | |
| Covidien LP | $27.45 | 2019 | |
| Baxter Healthcare | $22.89 | 2019 | |
| Csl Behring | $16.55 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $14.37 | 2019 | |
| Ekos Corporation | $13.90 | 2019 | |
| Z-Medica, LLC | $9.08 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Waldschmidt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.